Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review
Publication
, Conference
Lin, C; Scobie, M; Friedman, D; Kelley, M; Rodgers, T
Published in: Blood
November 15, 2022
Duke Scholars
Published In
Blood
DOI
ISSN
0006-4971
Publication Date
November 15, 2022
Volume
140
Issue
Supplemental 1
Start / End Page
4176 / 4177
Location
New Orleans, LA
Publisher
American Society of Hematology
Conference Name
American Society of Hematology Annual Meeting
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Lin, C., Scobie, M., Friedman, D., Kelley, M., & Rodgers, T. (2022). Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review. In Blood (Vol. 140, pp. 4176–4177). New Orleans, LA: American Society of Hematology. https://doi.org/10.1182/blood-2022-157414
Lin, Chenyu, Micaela Scobie, Daphne Friedman, Michael Kelley, and Thomas Rodgers. “Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review.” In Blood, 140:4176–77. American Society of Hematology, 2022. https://doi.org/10.1182/blood-2022-157414.
Lin C, Scobie M, Friedman D, Kelley M, Rodgers T. Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review. In: Blood. American Society of Hematology; 2022. p. 4176–7.
Lin, Chenyu, et al. “Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review.” Blood, vol. 140, no. Supplemental 1, American Society of Hematology, 2022, pp. 4176–77. Manual, doi:10.1182/blood-2022-157414.
Lin C, Scobie M, Friedman D, Kelley M, Rodgers T. Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review. Blood. American Society of Hematology; 2022. p. 4176–4177.
Published In
Blood
DOI
ISSN
0006-4971
Publication Date
November 15, 2022
Volume
140
Issue
Supplemental 1
Start / End Page
4176 / 4177
Location
New Orleans, LA
Publisher
American Society of Hematology
Conference Name
American Society of Hematology Annual Meeting
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology